Zobrazeno 1 - 10
of 128
pro vyhledávání: '"Kevin L Thomas"'
Publikováno v:
BMJ Open, Vol 12, Iss 11 (2022)
Objective To examine factors contributing to racial differences in 30-day readmission in patients with cardiovascular disease (CVD).Design Patients were enrolled from 1 January 2015 to 31 August 2017 and data were collected from electronic health rec
Externí odkaz:
https://doaj.org/article/2b383e8e1bd042319c9ac3fb731da22f
Autor:
Monique Anderson Starks, Gillian D Sanders, Remy Rene Coeytaux, Isaretta L Riley, Larry R Jackson, Amanda McBroom Brooks, Kevin L Thomas, Kingshuk Roy Choudhury, Robert M Califf, Adrian F Hernandez
Publikováno v:
PLoS ONE, Vol 14, Iss 8, p e0219894 (2019)
BackgroundCluster-randomized trials (CRTs) are being increasingly used to test a range of interventions, including medical interventions commonly used in clinical practice. Policies created by the NIH and the Food and Drug Administration (FDA) requir
Externí odkaz:
https://doaj.org/article/a454f84ba561459298d62ec9088b1231
Autor:
Brian C. Boursiquot, Rebecca Young, Brooke Alhanti, Lonnie T. Sullivan, Andrew J. Maul, Apurva Khedagi, Samuel F. Sears, Larry R. Jackson, Kevin L. Thomas
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 14 (2024)
Background Black patients meeting indications for implantable cardioverter‐defibrillators (ICDs) have lower rates of implantation compared with White patients. There is little understanding of how mental health impacts the decision‐making process
Externí odkaz:
https://doaj.org/article/eeda41339439493fa569eef39ccc4ba5
Autor:
Eric Black‐Maier, Benjamin A. Steinberg, Kevin M. Trulock, Frances Wang, Yuliya Lokhnygina, Wanda O'Neal, Sana Al‐Khatib, Brett D. Atwater, James P. Daubert, Camille Frazier‐Mills, Donald D. Hegland, Kevin P. Jackson, Larry R. Jackson, Jason I. Koontz, Robert K. Lewis, Albert Y. Sun, Kevin L. Thomas, Tristram D. Bahnson, Jonathan P. Piccini
Publikováno v:
Journal of Arrhythmia, Vol 36, Iss 1, Pp 84-92 (2020)
Abstract Background Catheter ablation is an important rhythm control therapy in patients with atrial fibrillation (AF) with concomitant heart failure (HF). The objective of this study was to assess the comparative efficacy of AF ablation patients wit
Externí odkaz:
https://doaj.org/article/ea3fbc84e35246c096d231f72685de92
Autor:
Kamala P. Tamirisa, MD, Sana M. Al-Khatib, MD, MHS, Sanghamitra Mohanty, MD, Janet K. Han, MD, Andrea Natale, MD, Dhiraj Gupta, MD, Andrea M. Russo, MD, Amin Al-Ahmad, MD, Anne M. Gillis, MD, Kevin L. Thomas, MD
Publikováno v:
CJC Open, Vol 3, Iss 12, Pp S137-S148 (2021)
Atrial fibrillation (AF) is the most common clinical arrhythmia, and it results in adverse outcomes and increased healthcare costs. Racial and ethnic differences in AF management, although recognized, are poorly understood. This review summarizes rac
Externí odkaz:
https://doaj.org/article/72c71a95eaec434b9348c752e4b45e9b
Autor:
Joseph Lunyera, Robert M. Clare, Karen Chiswell, Julia J. Scialla, Patrick H. Pun, Kevin L. Thomas, Monique A. Starks, Dinushika Mohottige, L. Ebony Boulware, Clarissa J. Diamantidis
Publikováno v:
American Journal of Kidney Diseases. 81:707-716
Autor:
Utibe R. Essien, Karen Chiswell, Lisa A. Kaltenbach, Tracy Y. Wang, Gregg C. Fonarow, Kevin L. Thomas, Mintu P. Turakhia, Emelia J. Benjamin, Fatima Rodriguez, Margaret C. Fang, Jared W. Magnani, Clyde W. Yancy, Jonathan P. Piccini
Publikováno v:
JAMA cardiology. 7(12)
ImportanceOral anticoagulation (OAC) is underprescribed in underrepresented racial and ethnic group individuals with atrial fibrillation (AF). Little is known of how differential OAC prescribing relates to inequities in AF outcomes.ObjectiveTo compar
Autor:
Sean D, Pokorney, Glenn M, Chertow, Hussein R, Al-Khalidi, Dianne, Gallup, Pat, Dignacco, Kurt, Mussina, Nisha, Bansal, Crystal A, Gadegbeku, David A, Garcia, Samira, Garonzik, Renato D, Lopes, Kenneth W, Mahaffey, Kelly, Matsuda, John P, Middleton, Jennifer A, Rymer, George H, Sands, Ravi, Thadhani, Kevin L, Thomas, Jeffrey B, Washam, Wolfgang C, Winkelmayer, Christopher B, Granger
Publikováno v:
Circulation. 146:1735-1745
Background: There are no randomized data evaluating the safety or efficacy of apixaban for stroke prevention in patients with end-stage kidney disease on hemodialysis and with atrial fibrillation (AF). Methods: The RENAL-AF trial (Renal Hemodialysis
Autor:
Duy T. Nguyen, Kenneth C. Bilchick, Sanjiv M. Narayan, Mina K. Chung, Kevin L. Thomas, Kenneth R. Laurita, Marmar Vaseghi, Roopinder Sandhu, Mihail G. Chelu, Prince J. Kannankeril, Douglas L. Packer, David D. McManus, Atul Verma, Matthew Singleton, Khaldoun Tarakji, Sana M. Al-Khatib, Jonathan R. Kaltman, Ravi C. Balijepalli, George F. Van Hare, Jodie L. Hurwitz, Andrea M. Russo, Fred M. Kusumoto, Christine M. Albert
Publikováno v:
Heart Rhythm. 19:1927-1945
Autor:
Kevin L. Thomas, Jalaj Garg, Poonam Velagapudi, Rakesh Gopinathannair, Mina K. Chung, Fred Kusumoto, Olujimi Ajijola, Larry R. Jackson, Mohit K. Turagam, Jose A. Joglar, Felix O. Sogade, John M. Fontaine, Andrew D. Krahn, Andrea M. Russo, Christine Albert, Dhanunjaya R. Lakkireddy
Publikováno v:
Heart Rhythm. 19:1577-1593